Explore more publications!

Tennessee Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tennessee Healthcare Today.

Press releases published on September 25, 2025

Adversity Into Adventure Joins Permobil’s Harvest Hoopla for a Day of Community and Support
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly
Medirom Decides to Double Installation of Authentication Device “Orb” to 200 Stores, in Collaboration with “World” Co-founded by Sam Altman and Alex Blania
Medicenna Announces Results of Annual Meeting of Shareholders
Teva Releases Q3 2025 Aide Memoire
Buying Guide 2025- most effective female libido booster pills in 2025 By OhYes
Medtimo Files Patent Infringement Complaint Against Allurion Technologies
LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call
CapsoVision to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations
Buying Guide 2025- Pills to Increase Sex Drive Female 2025 -Start Your Libido Life Today with Oh yes
Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI
SoCalBio Investor Conference Sessions to Spotlight Bioscience Workforce Development, Technology Transfer, and AI-Driven Innovation
AlphaTON Capital Corp Successfully Closes $71 million Financing and Completes Initial TON Token Acquisition
Andersen Sterilizers Launches EOGas 4PLUS: Next-Generation Low-Temperature Sterilization
AIMイムノテック (AIM ImmunoTech)、アンプリジェン (Ampligen®)(リンタトリモド) とチェックポイント阻害剤を併用する新規がん治療に関する特許を日本で2039年まで取得
Theratechnologies Announces Completion of Acquisition by Future Pak

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions